Cocrystal Pharma Correlations
| COCP Stock | USD 1.46 0.04 2.67% |
The current 90-days correlation between Cocrystal Pharma and AIM ImmunoTech is 0.25 (i.e., Modest diversification). The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Cocrystal Pharma Correlation With Market
Significant diversification
The correlation between Cocrystal Pharma and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cocrystal Pharma and DJI in the same portfolio, assuming nothing else is changed.
Cocrystal | Build AI portfolio with Cocrystal Stock |
Moving against Cocrystal Stock
| 0.38 | SLS | Sellas Life Sciences | PairCorr |
| 0.33 | AQB | AquaBounty Technologies Buyout Trend | PairCorr |
| 0.32 | IBIO | iBio, Common Stock | PairCorr |
| 0.32 | APGE | Apogee Therapeutics, | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Cocrystal Stock performing well and Cocrystal Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cocrystal Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AIM | 5.76 | (0.98) | 0.00 | 1.66 | 0.00 | 8.59 | 98.04 | |||
| AYTU | 3.06 | 0.24 | 0.10 | 0.21 | 3.28 | 6.91 | 40.64 | |||
| CLRB | 5.79 | 0.14 | 0.00 | 0.06 | 0.00 | 8.62 | 97.91 | |||
| CRVO | 3.63 | 0.43 | 0.08 | 4.93 | 4.08 | 7.72 | 20.68 | |||
| FBRX | 4.48 | 0.18 | 0.06 | 0.16 | 6.19 | 11.05 | 43.02 | |||
| PRPO | 2.88 | 0.88 | 0.31 | 38.17 | 2.06 | 6.64 | 21.13 | |||
| REVB | 3.78 | 0.07 | 0.05 | 0.14 | 4.05 | 12.50 | 25.07 | |||
| VRAX | 3.54 | (0.77) | 0.00 | (0.42) | 0.00 | 5.75 | 33.81 |
Cocrystal Pharma Corporate Executives
Elected by the shareholders, the Cocrystal Pharma's board of directors comprises two types of representatives: Cocrystal Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cocrystal. The board's role is to monitor Cocrystal Pharma's management team and ensure that shareholders' interests are well served. Cocrystal Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cocrystal Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sam Lee | Co-Founder and Pres | Profile | |
| Roger Kornberg | Independent CoFounder | Profile | |
| Prof Kornberg | Independent CoFounder | Profile |